| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00292-016-0217-1 |
| P698 | PubMed publication ID | 27638539 |
| P2093 | author name string | J Budczies | |
| P2860 | cites work | Oncometabolites-driven tumorigenesis: From genetics to targeted therapy | Q38240032 |
| Tissue-Based Metabolomics to Analyze the Breast Cancer Metabolome. | Q38936269 | ||
| Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer | Q39024340 | ||
| Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) | Q39253539 | ||
| Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism | Q46743426 | ||
| A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer | Q46799300 | ||
| Glutamate enrichment as new diagnostic opportunity in breast cancer. | Q52874359 | ||
| Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. | Q52929104 | ||
| HMDB 3.0--The Human Metabolome Database in 2013 | Q24595162 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression | Q24654019 | ||
| An Optimized Method of Metabolite Extraction from Formalin-Fixed Paraffin-Embedded Tissue for GC/MS Analysis | Q27320823 | ||
| Metabolomic profiling from formalin-fixed, paraffin-embedded tumor tissue using targeted LC/MS/MS: application in sarcoma | Q28477332 | ||
| Tumor cell metabolism: cancer's Achilles' heel | Q29619809 | ||
| Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate | Q33699608 | ||
| A joint analysis of metabolomics and genetics of breast cancer | Q34296486 | ||
| Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study | Q34348061 | ||
| Targeting mitochondrial glutaminase activity inhibits oncogenic transformation | Q34807996 | ||
| Metabolomics technology and bioinformatics | Q36505958 | ||
| Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate. | Q36759382 | ||
| Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover | Q36942649 | ||
| MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. | Q37410615 | ||
| Metabolic transformation in cancer. | Q37423585 | ||
| Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate | Q37632016 | ||
| Targeting metabolic transformation for cancer therapy. | Q37714309 | ||
| How cancer metabolism is tuned for proliferation and vulnerable to disruption | Q38059777 | ||
| P433 | issue | Suppl 2 | |
| P407 | language of work or name | German | Q188 |
| P304 | page(s) | 204-209 | |
| P577 | publication date | 2016-09-15 | |
| P1433 | published in | Pathologe | Q15749166 |
| P1476 | title | [Metabolome analysis of solid tumors]. | |
| P478 | volume | 37 |
Search more.